Document Detail

Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.
MedLine Citation:
PMID:  8421088     Owner:  NLM     Status:  MEDLINE    
To investigate the effect of low dose oral contraceptives on the low density lipoprotein (LDL) subfraction profile, the distribution of the LDL subfraction patterns in 20 premenopausal women on oral contraceptive (OC) therapy and 41 premenopausal women not taking gonadal hormones was studied. The LDL subfraction patterns were identified by density gradient ultracentrifugation and each individual LDL subfraction pattern was characterized by the relative contribution of three major LDL subfractions: light, LDL1; intermediate, LDL2; and dense, LDL3 to total LDL. Serum lipid and lipoprotein levels were similar in OC users and controls, except for significantly higher triglyceride levels in OC users. As for the LDL subfraction patterns, among the OC users the mean relative contribution of dense LDL3 to total LDL was significantly higher than in the controls (32% +/- 8% vs. 26% +/- 13%, P < 0.05), whereas the relative contribution of light LDL1 to total LDL was significantly lower (27% +/- 8% vs. 34% +/- 10%, P < 0.01), indicating a higher prevalence of the more dense LDL subfraction patterns among OC users. Furthermore, the distribution of the LDL subfraction patterns in OC users (27% LDL1, 41% LDL2, and 32% LDL3) resembled that of men (25% LDL1, 43% LDL2, and 33% LDL3, n = 59). Statistical analysis revealed that OC use was significantly associated with a more dense LDL subfraction pattern, characterized by an increased relative contribution of LDL3 (+6%, P < 0.05) and a decreased relative contribution of LDL1 (-6%, P < 0.01), even after correcting for the influence of lipid and lipoprotein levels, which in controls were shown to have a significant relation to LDL3 and LDL1, respectively. So, independent of the lipid and lipoprotein levels, low dose OC alter the composition of LDL to a heavy, dense LDL subfraction profile, which reportedly has been associated with an increased risk of atherosclerosis.
J de Graaf; D W Swinkels; P N Demacker; A F de Haan; A F Stalenhoef
Related Documents :
3510088 - The effects of changes in physical activity on major cardiovascular risk factors, hemod...
7500628 - Lipoprotein(a) and exercise.
11427768 - The acute versus the chronic response to exercise.
10778878 - Blood lipid response to 20 weeks of supervised exercise in a large biracial population:...
9754978 - Detection of the change point in oxygen uptake during an incremental exercise test usin...
18191758 - Systemic and mitochondrial adaptive responses to moderate exercise in rodents.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  76     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1993 Jan 
Date Detail:
Created Date:  1993-02-17     Completed Date:  1993-02-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  197-202     Citation Subset:  AIM; IM; J    
Department of Medicine, University Hospital Nijmegen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholesterol / blood
Contraceptives, Oral*
Contraceptives, Oral, Combined*
Lipoproteins, HDL / blood
Lipoproteins, LDL / blood*,  isolation & purification
Lipoproteins, VLDL / blood
Menopause / blood
Menstruation / blood
Middle Aged
Reference Values
Triglycerides / blood
Reg. No./Substance:
0/Contraceptives, Oral; 0/Contraceptives, Oral, Combined; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 0/Triglycerides; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate le...
Next Document:  Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with a...